Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics
This issue of the Heart Failure Clinics of North America, guest edited by Drs. Daniel Lenihan and Douglas Sawyer, will cover several aspects of Cardio-oncology Related to Heart Failure. Subjects discussed in the volume include, but are not limited to: Proteasome Inhibitors as a potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp; Epidemiology and common risk factors; Pediatric Considerations; Alternative biomarkers for combined biology; How to develop a Cardio-Oncology Clinic; and How to structure a Cardio-Oncology fellowship program, among others.
Cardio-Oncology
Co-edited and written by an interdisciplinary team of experts in oncology and cardiology, this book is a clinically useful resource on these overlapping topics: • Cardiac complications in patients receiving cancer therapy • The treatment of cancer in patients with cardiovascular disease • The treatment of cardiovascular disease in patients with cancer When relevant to medical practice, epidemiology and basic science are also included in the discussion and each chapter is written by an oncologist and a cardiologist. Additionally, the chapters follow a similar format to make the book truly interdisciplinary, user-friendly, and clinically applicable to specialists and non-specialists who care for patients with both cancer and cardiovascular disease.
Stage B, a Pre-cursor of Heart Failure, An Issue of Heart Failure Clinics
In the joint American College of Cardiology /American Heart Association classification system, Stage B heart failure refers to patients with structural heart disease but no symptoms of heart failure. Preventing progression of heart failure in Stage B patients is a central concern to heart failure specialists, so two issues have been devoted to this topic. Part I focuses on an understanding of structural heart disease and the factors that cause progression from risk of heart failure to development of structural changes.
Stage B, A Pre-cursor to Heart Failure, Part II, An Issue of Heart Failure Clinics
In the joint American College of Cardiology /American Heart Association classification system, Stage B heart failure refers to patients with structural heart disease but no symptoms of heart failure. Preventing progression of heart failure in Stage B patients is a central concern to heart failure specialists, so two issues have been devoted to this topic. Part II focuses on screening to identify patients with Stage B HF and monitoring and therapeutic approaches to patients with a diagnosis of Stage B HF.
Atlas of Heart Failure
In its third edition, the Atlas of Heart Failure provides a comprehensive up-to-date overview of normal cardiac function, the mechanisms of dysfunction in heart failure, and the therapeutic approaches that are available to manage the syndrome. Designed to provide a detailed and comprehensive visual exposition of all aspects of cardiac function and dysfunction, this atlas contains several hundred images, each accompanied by detailed captions, carefully selected by expert authors, and reviewed by the editor.
Atlas of HEART FAILURE
Now in its fourth edition, the Atlas of Heart Failure provides a comprehensive up-to-date overview of normal cardiac function, the mechanisms of dysfunction in heart failure, and the therapeutic approaches that are available to manage the syndrome. Designed to provide a detailed and comprehensive visual exposition of all aspects of cardiac function and dysfunction, this atlas contains several hundred images, each accompanied by detailed captions, carefully selected by expert authors, and reviewed by the editor.
Pathophysiology of Cardiovascular Disease
Pathophysiology of Cardiovascular Disease has been divided into four sections that focus on heart dysfunction and its associated characteristics (hypertrophy, cardiomyopathy and failure); vascular dysfunction and disease; ischemic heart disease; and novel therapeutic interventions. This volume is a compendium of different approaches to understanding cardiovascular disease and identifying the proteins, pathways and processes that impact it.
